Literature DB >> 31575672

Hereditary thrombotic thrombocytopenic purpura.

Marie Scully1.   

Abstract

Entities:  

Year:  2019        PMID: 31575672      PMCID: PMC6886428          DOI: 10.3324/haematol.2019.225896

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Studies on thrombopoiesis. I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency.

Authors:  I SCHULMAN; M PIERCE; A LUKENS; Z CURRIMBHOY
Journal:  Blood       Date:  1960-07       Impact factor: 22.113

2.  Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia.

Authors:  J D Upshaw
Journal:  N Engl J Med       Date:  1978-06-15       Impact factor: 91.245

3.  Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura.

Authors:  A Taylor; C Vendramin; S Oosterholt; O Della Pasqua; M Scully
Journal:  J Thromb Haemost       Date:  2018-12-31       Impact factor: 5.824

4.  Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.

Authors:  M Furlan; R Robles; B Morselli; P Sandoz; B Lämmle
Journal:  Thromb Haemost       Date:  1999-01       Impact factor: 5.249

5.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

6.  Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura.

Authors:  R S Camilleri; H Cohen; I J Mackie; M Scully; R D Starke; J T B Crawley; D A Lane; S J Machin
Journal:  J Thromb Haemost       Date:  2007-11-20       Impact factor: 5.824

7.  Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.

Authors:  Koichi Kokame; Masanori Matsumoto; Kenji Soejima; Hideo Yagi; Hiromichi Ishizashi; Masahisa Funato; Hiroshi Tamai; Mutsuko Konno; Kei Kamide; Yuhei Kawano; Toshiyuki Miyata; Yoshihiro Fujimura
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

8.  Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes.

Authors:  Marie Scully; Mari Thomas; Mary Underwood; Henry Watson; Katherine Langley; Raymond S Camilleri; Amanda Clark; Desmond Creagh; Rachel Rayment; Vickie Mcdonald; Ashok Roy; Gillian Evans; Siobhan McGuckin; Fionnuala Ni Ainle; Rhona Maclean; William Lester; Michael Nash; Rosemary Scott; Patrick O Brien
Journal:  Blood       Date:  2014-05-23       Impact factor: 22.113

9.  The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017.

Authors:  Hendrika A van Dorland; Magnus Mansouri Taleghani; Kazuya Sakai; Kenneth D Friedman; James N George; Ingrid Hrachovinova; Paul N Knöbl; Anne Sophie von Krogh; Reinhard Schneppenheim; Isabella Aebi-Huber; Lukas Bütikofer; Carlo R Largiadèr; Zuzana Cermakova; Koichi Kokame; Toshiyuki Miyata; Hideo Yagi; Deirdra R Terrell; Sara K Vesely; Masanori Matsumoto; Bernhard Lämmle; Yoshihiro Fujimura; Johanna A Kremer Hovinga
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941

10.  Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura.

Authors:  Marie Scully; Christopher Hibbard; Bruce Ewenstein
Journal:  Oncoscience       Date:  2017-11-28
View more
  2 in total

1.  [Recurrent thrombocytopenia with hemolytic anemia in a boy aged 3 years].

Authors:  Min-Hui Zeng; Xiang-Ling He; Xin Tian; Yu-Hui Huang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-05

Review 2.  TTP: From empiricism for an enigmatic disease to targeted molecular therapies.

Authors:  Nuno A G Graça; Bérangère S Joly; Jan Voorberg; Karen Vanhoorelbeke; Nicolas Béranger; Agnès Veyradier; Paul Coppo
Journal:  Br J Haematol       Date:  2022-02-10       Impact factor: 8.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.